ATE376840T1 - Gentherapeutika - Google Patents

Gentherapeutika

Info

Publication number: ATE376840T1
Authority: AT; Austria
Prior art keywords: gene; affinity; functional substance; efficacious amount; gene therapeutics
Prior art date: 1999-03-23

Application number

AT00908055T

Other languages

English (en)

Inventor

Ikunoshin Kato

Kiyozo Asada

Mitsuhiro Ueno

Kimikazu Hashino

Hirofumi Yoshioka

Keiji Tanaka

Original Assignee

Takara Bio Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-03-23

Filing date

2000-03-14

Publication date

2007-11-15

2000-03-14 Application filed by Takara Bio Inc filed Critical Takara Bio Inc

2007-11-15 Application granted granted Critical

2007-11-15 Publication of ATE376840T1 publication Critical patent/ATE376840T1/de

Links

108090000623 proteins and genes Proteins 0.000 title abstract 4
239000003814 drug Substances 0.000 title abstract 2
239000000126 substance Substances 0.000 abstract 3
241000700605 Viruses Species 0.000 abstract 2
238000001415 gene therapy Methods 0.000 abstract 2
239000004480 active ingredient Substances 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
230000035945 sensitivity Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10041—Use of virus, viral particle or viral elements as a vector
- C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13041—Use of virus, viral particle or viral elements as a vector
- C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/40—Vectors comprising a peptide as targeting moiety, e.g. a synthetic peptide, from undefined source

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Biotechnology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Plant Pathology (AREA)
Virology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Physics & Mathematics (AREA)
Immunology (AREA)
Mycology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT00908055T 1999-03-23 2000-03-14 Gentherapeutika ATE376840T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP7859199		1999-03-23

Publications (1)

Publication Number	Publication Date
ATE376840T1 true ATE376840T1 (de)	2007-11-15

Family

ID=13666162

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00908055T ATE376840T1 (de)	1999-03-23	2000-03-14	Gentherapeutika

Country Status (9)

Country	Link
US (1)	US20060166924A1 (de)
EP (1)	EP1163912B1 (de)
KR (1)	KR100674140B1 (de)
CN (1)	CN1225285C (de)
AT (1)	ATE376840T1 (de)
AU (1)	AU2944100A (de)
DE (1)	DE60036929T2 (de)
TW (1)	TWI272107B (de)
WO (1)	WO2000056368A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI311586B (en)	2001-08-15	2009-07-01	Takara Bio Inc	Method of extended culture for antigen-specific cytotoxic t lumphocytes
EP2305796B1 (de)	2002-03-25	2012-10-24	Takara Bio Inc.	Verfahren zur Hestellung von zytotoxischen Lymphozyten
KR101331746B1 (ko)	2003-08-22	2013-11-20	다카라 바이오 가부시키가이샤	세포 상해성 림프구의 제조 방법
EP1916302A4 (de)	2005-08-17	2009-10-21	Takara Bio Inc	Verfahren zur herstellung von lymphozyten
JP5156382B2 (ja) *	2005-09-30	2013-03-06	タカラバイオ株式会社	Ｔ細胞集団の製造方法
CN114401740A (zh) *	2019-05-30	2022-04-26	伊美诺路克斯国际公司	痘病毒与自体诱导性多能干细胞用于疫苗接种和疾病治疗的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5686278A (en) *	1994-03-25	1997-11-11	Indiana University Foundation	Methods for enhanced retrovirus-mediated gene transfer
WO1995031566A1 (en) *	1994-05-13	1995-11-23	Chiron Viagene, Inc.	Compositions and methods for targeting gene delivery vehicles
GB9506466D0 (en) *	1994-08-26	1995-05-17	Prolifix Ltd	Cell cycle regulated repressor and dna element
FR2726005B1 (fr) *	1994-10-10	1997-01-03	Adim	Lignees immortalisees de cellules endotheliales cerebrales et leurs applications au traitement de differents troubles ou maladies primaires et secondaires neurologiques ou psychiatriques
CA2235629A1 (en) *	1995-11-13	1997-05-22	Takara Shuzo Co., Ltd.	Method for gene transfer into target cells with retrovirus
WO1997031656A1 (fr) *	1996-03-01	1997-09-04	Dnavec Research Inc.	Composition pour introduire de maniere stable des genes dans des cellules hepatiques et procede pour introduire des genes a l'aide de cette composition
ATE350482T1 (de) *	1998-07-01	2007-01-15	Takara Bio Inc	Gentransfermethoden

2000
- 2000-03-14 KR KR1020017011459A patent/KR100674140B1/ko not_active Expired - Fee Related
- 2000-03-14 CN CNB008054673A patent/CN1225285C/zh not_active Expired - Fee Related
- 2000-03-14 AU AU29441/00A patent/AU2944100A/en not_active Abandoned
- 2000-03-14 EP EP00908055A patent/EP1163912B1/de not_active Expired - Lifetime
- 2000-03-14 AT AT00908055T patent/ATE376840T1/de not_active IP Right Cessation
- 2000-03-14 WO PCT/JP2000/001533 patent/WO2000056368A1/ja not_active Ceased
- 2000-03-14 DE DE60036929T patent/DE60036929T2/de not_active Expired - Lifetime
- 2000-03-16 TW TW089104822A patent/TWI272107B/zh not_active IP Right Cessation
2006
- 2006-03-28 US US11/390,345 patent/US20060166924A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU2944100A (en)	2000-10-09
KR20010102547A (ko)	2001-11-15
EP1163912A1 (de)	2001-12-19
KR100674140B1 (ko)	2007-01-26
US20060166924A1 (en)	2006-07-27
CN1345248A (zh)	2002-04-17
TWI272107B (en)	2007-02-01
WO2000056368A1 (en)	2000-09-28
EP1163912A4 (de)	2003-08-06
EP1163912B1 (de)	2007-10-31
CN1225285C (zh)	2005-11-02
DE60036929D1 (de)	2007-12-13
DE60036929T2 (de)	2008-08-07

Legal Events

Date	Code	Title	Description
2008-04-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
BR0316234A (pt)	2005-10-11	Hidroxiindóis, seu uso como inibidores de fosfodiesterase 4 e processos para a preparação dos mesmos
ATE308999T1 (de)	2005-11-15	Intrazellulare expression von carboxypeptidase g2 in enzyme-prodrug-therapie
DE50211045D1 (de)	2007-11-22	Medizinische aerosolformulierungen
TR200002355T2 (tr)	2000-11-21	2-(Pürin-9-il)tetrahidrofüran-3,4-diol türevleri
HN1998000143A (es)	1999-04-09	Tetrahidronaftalenos substituidos y compuestos analogos.
EP1411118A4 (de)	2005-01-26	Zellproliferationsinhibitoren mit anti-glypican-3-antikörper
TR199800046A2 (xx)	1998-10-21	Aktif maddeler yarat�lmas� i�in n�kleik asit olu�umu.
NO20025450D0 (no)	2002-11-14	Ny farmasöytisk sammensetning
ATE231509T1 (de)	2003-02-15	1,5-dihydro-pyrazolo 3,4-d)-pyrimidinon-derivate
DE60016798D1 (de)	2005-01-20	Papiertuch enthaltend antivirale wirkstoffe die hautfreundlich sind
BR0009170A (pt)	2002-04-30	ácidos nucléicos akt, polipeptìdeos e uso dos mesmos
DE60036929D1 (de)	2007-12-13	Gentherapeutika
DE60132443D1 (de)	2008-03-06	In lebenden zielzellen
NO20041773L (no)	2004-06-29	Farmasoytiske preparater for reduksjon av cellers aktivitet samt deres anvendelse.
EP1295611A4 (de)	2009-07-08	Verbindungen für den transfer von oligonukleotiden(03.01.02)
ES2124861T3 (es)	1999-02-16	Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa.
SE9803272D0 (sv)	1998-09-25	A drug for cell regeneration
EP1163373A4 (de)	2002-08-07	Antisense-modulation des zellulären hemmstoffs der apoptosis-expression
DE60125232D1 (de)	2007-01-25	Kleines säurelösliches sporenprotein und seine verwendungen
DK52685A (da)	1985-09-20	N,3-diacyl-2-oxindol-1-carboxamid-forbindelser og mellemprodukter ved deres fremstilling samt farmaceutisk praeparat
TR200201148T2 (tr)	2002-10-21	Haşerat ilacı terkipleri ve metodları.
MEP18508A (en)	2010-06-10	Pharmaceutical composition and preparation thereof
BRPI0409683A (pt)	2006-04-18	5-hidroxiindóis com grupos n-óxido e seu emprego como agentes terapêuticos
DK592885A (da)	1986-06-22	2-azolylmethyl-3-difluorbenzyloxy-2,3-dihydrofluor-benzo(b)thiophener, fremgangsmaade til deres fremstilling og kompositioner indeholdendeforbindelserne
FI20030379A0 (fi)	2003-03-14	Uusi farmaseuttinen koostumus